Lord, Abbett & Co
AKYA

Lord, Abbett & Co’s Akoya BioSciences AKYA Stock Holding History

Lord, Abbett & Co’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-284,946
Closed -$2.73M – 542
2022
Q4 		$2.73M Buy
+284,946
New +$3.51M 0.01% 535
2021
Q4 		– Sell
-263,913
Closed -$3.68M – 599
2021
Q3 		$3.68M Buy
263,913
+369
+0.1% +$6.17K 0.01% 609
2021
Q2 		$5.1M Buy
+263,544
New +$5.44M 0.01% 608

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Lord, Abbett & Co's AKYA Position: Q1 2023 in Review

Lord, Abbett & Co sold out of Akoya BioSciences (AKYA) in Q1 2023, closing a stake of 284,946 shares — an estimated $2.73M sold.

Lord, Abbett & Co first reported a position in AKYA in Q2 2021 and held it in 3 quarters. The position peaked at $5.1M in Q2 2021. 63 funds tracked by Wall St. Rank hold AKYA as of Q1 2023.

  • Lord, Abbett & Co reported no remaining Akoya BioSciences position as of Q1 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 284,946 Akoya BioSciences shares in Q1 2023, an estimated $2.73M.
  • Lord, Abbett & Co first reported a position in Akoya BioSciences in Q2 2021 and held it in 3 quarters.
  • Lord, Abbett & Co's Akoya BioSciences position peaked at $5.1M in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2023.

Based on Lord, Abbett & Co's 13F filing for Q1 2023, filed 12 May 2023.